Some Humana plans in Arizona may cover GLP-1 medications for weight loss when prescribed for a qualifying diagnosis and approved through prior authorization
The objective was to evaluate the effectiveness and safety, with a specific focus on cardiovascular safety, of tirzepatide, a novel dual GIP and GLP-1 receptor agonist, compared to insulin glargine in adults with type 2 diabetes and a high risk of cardiovascular events who have not achieved adequate control with oral glucose-lowering medications.This phase 3 study was conducted at 187 sites across 14 countries on five continents
Medications affecting clotting, such as anticoagulants (including warfarin and direct oral anticoagulants), may also contribute to increased menstrual blood loss
Sci Transl Med 2013;5:209ra151.ArticlePubMed 5
The bad news is that that affirms the link between oxidative stress and migraines
Impact of Sodium-Glucose Co-Transporter 2 Inhibitors Use on the Outcomes of Inflammatory Bowel Disease: A US Cohort Propensity-Matched Study
